Deep visual multi-omics profiling reveals mechanisms that underly cancer cell differentiation and aggressiveness in clear cell renal cell carcinoma
Bolck, H. A.; Migh, E.; Kriston, A.; Zajac, N.; Kreutzer, S.; Totu, T.; Leary, P.; Kovacs, F.; Rutishauser, D.; Pfammatter, S.; Grossmann, J.; Litchfield, C.; Buljan, M.; Rupp, N. J. A.; Horvath, P.; Moch, H.
Show abstract
Clear cell renal cell carcinoma (ccRCC) exhibits significant intra-tumoral heterogeneity (ITH) at both morphological and genetic levels, complicating treatment and contributing to disease progression. Among these, ccRCCs with focal rhabdoid differentiation stand out as highly aggressive tumors distinguished by cells with unique morphological features. However, the correlation between distinct morphological phenotypes, specific molecular alterations, and their influence on tumor behavior remains poorly understood. In this study, we integrated advanced AI-based image analysis with single-cell isolation and multi-omics profiling to dissect the link between clinically relevant morphological and molecular features of ccRCC cells. Using a novel digital pathology workflow, we quantified low-grade, high-grade, and rhabdoid morphologies in ccRCC diagnostic images with unprecedented precision. Subsequently, isolation of two sets of 1,000 morphologically distinct cells for detailed mRNA and protein expression analyses, revealed significant increasing dysregulation associating with higher histopathological grades. Rhabdoid ccRCC cells (grade 4) demonstrated unique molecular profiles, including upregulated FOXM1-driven proliferation, disrupted cell-matrix interactions, and enhanced immune evasion pathways. Despite high T-cell infiltration in rhabdoid areas, we identified a rhabdoid-specific immunosuppressive network driven by cytokines, IFN-beta, and integrin signaling, likely contributing to T-cell exhaustion. Rhabdoid ccRCC cells develop a distinct immunosuppressive signaling network, involving PD-L1 and novel immunomodulatory factors such as CD38 and ITGB2. These findings provide a basis for novel therapeutic strategies targeting these pathways in combination with immunotherapy to improve outcomes for patients with aggressive rhabdoid ccRCC. Key PointsO_LIccRCC is characterized by well-established morphological heterogeneity but the correlation with the underlying molecular aberrations remained elusive. C_LIO_LIBy integrating AI-based image analysis with single cell isolation and deep multi-omics profiling, we dissect the molecular intricacies of ccRCC, from targeted collection of 1,000 morphologically distinct cells. C_LIO_LIOur results demonstrate significant dysregulation of gene and protein expression correlating with higher histopathological grades in ccRCC. C_LIO_LIAggressive ccRCC cells with rhabdoid differentiation (grade 4) display distinct molecular profiles, as they upregulate FOXM1-mediated proliferation, ECM remodeling and the immune evasion responses, suggesting new therapeutic avenues enhancing ICI efficacy in these patients. C_LI
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Single-Cell RNA Sequencing Reveals the Effects of Chemotherapy on Human Pancreatic Adenocarcinoma and its Tumor Microenvironment 97%
- Integrative Molecular Characterization of Sarcomatoid and Rhabdoid Renal Cell Carcinoma Reveals Determinants of Poor Prognosis and Response to Immune Checkpoint Inhibitors 96%
- Spatial transcriptomics reveals ovarian cancer subclones with distinct tumour microenvironments 96%
Similar papers in this journal
- Determination of permissive and restraining cancer-associated fibroblast (DeCAF) subtypes 96%
- Conserved angio-immune subtypes of the cancer microenvironment predict response to immune checkpoint blockade therapy 95%
- Inflammatory reprogramming of the tumor microenvironment by infiltrating clonal hematopoiesis is associated with adverse outcomes in solid cancer 95%
Similar papers in this journal
- Evaluating the transcriptional fidelity of cancer models 95%
- SiRCle (Signature Regulatory Clustering) model integration reveals mechanisms of phenotype regulation in renal cancer 95%
- DNA methylation reveals distinct cells of origin for pancreatic neuroendocrine carcinomas (PanNECs) and pancreatic neuroendocrine tumors (PanNETs) 94%
Similar papers in this journal
- Single-cell transcriptional profiling of clear cell renal cell carcinoma reveals an invasive tumor vasculature phenotype 98%
- Epigenetic landscape of pancreatic neuroendocrine tumours reveals distinct cells of origin and means of tumour progression 95%
- Comparative analysis of syngeneic mouse models of high-grade serous ovarian cancer 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.